To assess early phase safety and tolerability of converting patients from approved oral, ...
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess ...
To determine the long-term (approximately 2 years) nephroprotective potential of treatment ...
Register to get notifications about clinical trials in your area.
Register to Receive Updates